Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
ABMD's Cash-to-Debt is ranked higher than
99% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. ABMD: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
ABMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 13.95  Med: No Debt Max: No Debt
Current: No Debt
13.95
No Debt
Equity-to-Asset 0.89
ABMD's Equity-to-Asset is ranked higher than
91% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. ABMD: 0.89 )
Ranked among companies with meaningful Equity-to-Asset only.
ABMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52  Med: 0.86 Max: 0.95
Current: 0.89
0.52
0.95
Interest Coverage No Debt
ABMD's Interest Coverage is ranked higher than
72% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 66.37 vs. ABMD: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ABMD' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 118.81
Beneish M-Score: -2.45
WACC vs ROIC
14.69%
52.66%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 27.44
ABMD's Operating Margin % is ranked higher than
93% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. ABMD: 27.44 )
Ranked among companies with meaningful Operating Margin % only.
ABMD' s Operating Margin % Range Over the Past 10 Years
Min: -40.32  Med: 7.51 Max: 27.44
Current: 27.44
-40.32
27.44
Net Margin % 27.60
ABMD's Net Margin % is ranked higher than
87% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. ABMD: 27.60 )
Ranked among companies with meaningful Net Margin % only.
ABMD' s Net Margin % Range Over the Past 10 Years
Min: -43.16  Med: 6.75 Max: 49.36
Current: 27.6
-43.16
49.36
ROE % 27.66
ABMD's ROE % is ranked higher than
87% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. ABMD: 27.66 )
Ranked among companies with meaningful ROE % only.
ABMD' s ROE % Range Over the Past 10 Years
Min: -30.15  Med: 8.11 Max: 49.44
Current: 27.66
-30.15
49.44
ROA % 24.42
ABMD's ROA % is ranked higher than
92% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -0.26 vs. ABMD: 24.42 )
Ranked among companies with meaningful ROA % only.
ABMD' s ROA % Range Over the Past 10 Years
Min: -24.88  Med: 6.6 Max: 41.81
Current: 24.42
-24.88
41.81
ROC (Joel Greenblatt) % 111.29
ABMD's ROC (Joel Greenblatt) % is ranked higher than
95% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 3.87 vs. ABMD: 111.29 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ABMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -144.89  Med: 67.56 Max: 171.62
Current: 111.29
-144.89
171.62
3-Year Revenue Growth Rate 34.10
ABMD's 3-Year Revenue Growth Rate is ranked higher than
93% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. ABMD: 34.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ABMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -12.5  Med: 14.4 Max: 51.9
Current: 34.1
-12.5
51.9
3-Year EBITDA Growth Rate 71.00
ABMD's 3-Year EBITDA Growth Rate is ranked higher than
99% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. ABMD: 71.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ABMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -11 Max: 102.2
Current: 71
0
102.2
3-Year EPS without NRI Growth Rate -2.60
ABMD's 3-Year EPS without NRI Growth Rate is ranked higher than
98% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 7.80 vs. ABMD: -2.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ABMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -18.6 Max: 304.6
Current: -2.6
0
304.6
GuruFocus has detected 2 Warning Signs with Abiomed Inc ABMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ABMD's 30-Y Financials

Financials (Next Earnings Date: 2019-01-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

ABMD Guru Trades in Q3 2017

Jim Simons 1,088,424 sh (+21.85%)
Chuck Royce 20,000 sh (unchged)
PRIMECAP Management 4,217,890 sh (-4.88%)
» More
Q4 2017

ABMD Guru Trades in Q4 2017

Lee Ainslie 32,580 sh (New)
Pioneer Investments 65,028 sh (New)
Joel Greenblatt 5,297 sh (New)
Jim Simons 1,082,723 sh (-0.52%)
PRIMECAP Management 4,079,390 sh (-3.28%)
Chuck Royce 10,000 sh (-50.00%)
» More
Q1 2018

ABMD Guru Trades in Q1 2018

Caxton Associates 2,979 sh (New)
Pioneer Investments 69,555 sh (+6.96%)
Jim Simons 1,149,623 sh (+6.18%)
Chuck Royce 10,000 sh (unchged)
Lee Ainslie Sold Out
Joel Greenblatt Sold Out
PRIMECAP Management 3,822,690 sh (-6.29%)
» More
Q2 2018

ABMD Guru Trades in Q2 2018

Jim Simons 1,551,423 sh (+34.95%)
Pioneer Investments 93,306 sh (+34.15%)
Caxton Associates 2,968 sh (-0.37%)
PRIMECAP Management 3,561,940 sh (-6.82%)
Chuck Royce 2,000 sh (-80.00%)
» More
» Details

Insider Trades

Latest Guru Trades with NAS:ABMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:NYSE:TFX, XSWX:SOON, NYSE:VAR, SZSE:300003, OCSE:WDH, LSE:SN., XPAR:DIM, ASX:COH, NAS:ALGN, LSE:CTEC, NZSE:FPH, NYSE:GMED, OCSE:AMBU B, NAS:IART, OCSE:GN, NAS:MASI, OSTO:EKTA B, NYSE:PEN, NAS:LIVN, SZSE:002223 » details
Traded in other countries:AIO.Germany,
Headquarter Location:USA
Abiomed Inc is a medical device company. It provides mechanical circulatory support devices to aid heart recovery to heart failure patients.

Abiomed provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Top Ranked Articles about Abiomed Inc

Abiomed Leads This Year’s Stock Market Race As the stock-market race enters the final laps for 2018, Abiomed Inc. is the best-performing stock in the S&P 500
As the stock-market race enters the final laps for 2018, Abiomed Inc. is the best-performing stock in the Standard & Poor’s 500 Index. Read more...
Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY
Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification
Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival
Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated
Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification
Report: Developing Opportunities within ABIOMED, Avid Technology, Unit, Omeros, Strayer Education, and NeoGenomics — Future Expectations, Projections Moving into 2018
Abiomed to Present at the Jefferies 2018 Healthcare Conference
ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Ratios

vs
industry
vs
history
PE Ratio 82.07
ABMD's PE Ratio is ranked lower than
94% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 30.17 vs. ABMD: 82.07 )
Ranked among companies with meaningful PE Ratio only.
ABMD' s PE Ratio Range Over the Past 10 Years
Min: 22.02  Med: 101.03 Max: 615.5
Current: 82.07
22.02
615.5
PE Ratio without NRI 82.07
ABMD's PE Ratio without NRI is ranked lower than
94% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.17 vs. ABMD: 82.07 )
Ranked among companies with meaningful PE Ratio without NRI only.
ABMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 22.02  Med: 101.03 Max: 615.5
Current: 82.07
22.02
615.5
Price-to-Owner-Earnings 112.93
ABMD's Price-to-Owner-Earnings is ranked lower than
88% of the 104 Companies
in the Global Medical Devices industry.

( Industry Median: 32.03 vs. ABMD: 112.93 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ABMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 44.38  Med: 100.36 Max: 201.19
Current: 112.93
44.38
201.19
PB Ratio 19.25
ABMD's PB Ratio is ranked lower than
95% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. ABMD: 19.25 )
Ranked among companies with meaningful PB Ratio only.
ABMD' s PB Ratio Range Over the Past 10 Years
Min: 1.61  Med: 6.36 Max: 27.52
Current: 19.25
1.61
27.52
PS Ratio 22.63
ABMD's PS Ratio is ranked lower than
89% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. ABMD: 22.63 )
Ranked among companies with meaningful PS Ratio only.
ABMD' s PS Ratio Range Over the Past 10 Years
Min: 2.38  Med: 6.78 Max: 31.82
Current: 22.63
2.38
31.82
Price-to-Free-Cash-Flow 101.01
ABMD's Price-to-Free-Cash-Flow is ranked lower than
92% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 26.44 vs. ABMD: 101.01 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ABMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 23.56  Med: 68.28 Max: 1172.38
Current: 101.01
23.56
1172.38
Price-to-Operating-Cash-Flow 70.93
ABMD's Price-to-Operating-Cash-Flow is ranked lower than
92% of the 127 Companies
in the Global Medical Devices industry.

( Industry Median: 20.01 vs. ABMD: 70.93 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ABMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 21.72  Med: 53.86 Max: 430.93
Current: 70.93
21.72
430.93
EV-to-EBIT 78.44
ABMD's EV-to-EBIT is ranked lower than
93% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.76 vs. ABMD: 78.44 )
Ranked among companies with meaningful EV-to-EBIT only.
ABMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -305.5  Med: 59.8 Max: 694.7
Current: 78.44
-305.5
694.7
EV-to-EBITDA 73.76
ABMD's EV-to-EBITDA is ranked lower than
95% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 18.14 vs. ABMD: 73.76 )
Ranked among companies with meaningful EV-to-EBITDA only.
ABMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -397.6  Med: 56.6 Max: 727.3
Current: 73.76
-397.6
727.3
EV-to-Revenue 21.53
ABMD's EV-to-Revenue is ranked lower than
86% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 3.73 vs. ABMD: 21.53 )
Ranked among companies with meaningful EV-to-Revenue only.
ABMD' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.7  Med: 6.4 Max: 31.4
Current: 21.53
1.7
31.4
PEG Ratio 1.53
ABMD's PEG Ratio is ranked higher than
57% of the 77 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. ABMD: 1.53 )
Ranked among companies with meaningful PEG Ratio only.
ABMD' s PEG Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.42 Max: 2.07
Current: 1.53
0.93
2.07
Shiller PE Ratio 351.96
ABMD's Shiller PE Ratio is ranked lower than
100% of the 58 Companies
in the Global Medical Devices industry.

( Industry Median: 49.95 vs. ABMD: 351.96 )
Ranked among companies with meaningful Shiller PE Ratio only.
ABMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 344.11  Med: 507.2 Max: 12369
Current: 351.96
344.11
12369
Current Ratio 6.85
ABMD's Current Ratio is ranked higher than
82% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. ABMD: 6.85 )
Ranked among companies with meaningful Current Ratio only.
ABMD' s Current Ratio Range Over the Past 10 Years
Min: 3.18  Med: 6.66 Max: 32.71
Current: 6.85
3.18
32.71
Quick Ratio 6.07
ABMD's Quick Ratio is ranked higher than
85% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. ABMD: 6.07 )
Ranked among companies with meaningful Quick Ratio only.
ABMD' s Quick Ratio Range Over the Past 10 Years
Min: 2  Med: 5.56 Max: 31.29
Current: 6.07
2
31.29
Days Inventory 162.13
ABMD's Days Inventory is ranked lower than
57% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 143.61 vs. ABMD: 162.13 )
Ranked among companies with meaningful Days Inventory only.
ABMD' s Days Inventory Range Over the Past 10 Years
Min: 138.81  Med: 154.05 Max: 287.59
Current: 162.13
138.81
287.59
Days Sales Outstanding 39.24
ABMD's Days Sales Outstanding is ranked higher than
87% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 69.21 vs. ABMD: 39.24 )
Ranked among companies with meaningful Days Sales Outstanding only.
ABMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.24  Med: 51.71 Max: 78.39
Current: 39.24
39.24
78.39
Days Payable 68.99
ABMD's Days Payable is ranked higher than
70% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 58.34 vs. ABMD: 68.99 )
Ranked among companies with meaningful Days Payable only.
ABMD' s Days Payable Range Over the Past 10 Years
Min: 60.98  Med: 91.92 Max: 106.56
Current: 68.99
60.98
106.56

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.40
ABMD's 3-Year Average Share Buyback Ratio is ranked higher than
60% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. ABMD: -2.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ABMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -14.9  Med: -3 Max: -0.5
Current: -2.4
-14.9
-0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 48.29
ABMD's Price-to-Net-Cash is ranked lower than
87% of the 104 Companies
in the Global Medical Devices industry.

( Industry Median: 14.24 vs. ABMD: 48.29 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ABMD' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.29  Med: 11.65 Max: 77.17
Current: 48.29
1.29
77.17
Price-to-Net-Current-Asset-Value 32.66
ABMD's Price-to-Net-Current-Asset-Value is ranked lower than
88% of the 207 Companies
in the Global Medical Devices industry.

( Industry Median: 7.79 vs. ABMD: 32.66 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ABMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.08  Med: 7.39 Max: 44.95
Current: 32.66
1.08
44.95
Price-to-Tangible-Book 20.53
ABMD's Price-to-Tangible-Book is ranked lower than
91% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. ABMD: 20.53 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ABMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1  Med: 5.54 Max: 27.26
Current: 20.53
1
27.26
Price-to-Intrinsic-Value-Projected-FCF 9.41
ABMD's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
90% of the 121 Companies
in the Global Medical Devices industry.

( Industry Median: 2.44 vs. ABMD: 9.41 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ABMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 4.39  Med: 7.59 Max: 163.8
Current: 9.41
4.39
163.8
Price-to-Median-PS-Value 3.34
ABMD's Price-to-Median-PS-Value is ranked lower than
97% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. ABMD: 3.34 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ABMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.34  Med: 1.08 Max: 6.25
Current: 3.34
0.34
6.25
Price-to-Peter-Lynch-Fair-Value 3.28
ABMD's Price-to-Peter-Lynch-Fair-Value is ranked lower than
89% of the 47 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. ABMD: 3.28 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ABMD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 2.31  Med: 4.25 Max: 35.22
Current: 3.28
2.31
35.22
Price-to-Graham-Number 8.65
ABMD's Price-to-Graham-Number is ranked lower than
95% of the 133 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. ABMD: 8.65 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ABMD' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 2.99  Med: 6.46 Max: 15.52
Current: 8.65
2.99
15.52
Earnings Yield (Greenblatt) % 1.26
ABMD's Earnings Yield (Greenblatt) % is ranked higher than
52% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.74 vs. ABMD: 1.26 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ABMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -24  Med: 0.9 Max: 3.7
Current: 1.26
-24
3.7
Forward Rate of Return (Yacktman) % 20.42
ABMD's Forward Rate of Return (Yacktman) % is ranked higher than
84% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 6.60 vs. ABMD: 20.42 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ABMD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -40.8  Med: 0.8 Max: 20.9
Current: 20.42
-40.8
20.9

More Statistics

Revenue (TTM) (Mil) $690.25
EPS (TTM) $ 4.13
Beta1.91
Volatility50.98%
52-Week Range $186.72 - 459.75
Shares Outstanding (Mil)45.04

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}